WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

IN-VITRO ACTIVITY OF TIGECYCLINE AGAINST CLINICAL ISOLATES OF ACINETOBACTER BAUMANNII BY E-TEST METHOD IN RABAT

*Es-said Imane, Benouda Amina 

ABSTRACT

Introduction: The progressively increasing resistance of A. baumannii to widely used antibiotics such as broad spectrum cephalosporins, carbapenems, fluoroquinolones and aminoglycosides is a major problem, urgently requiring more antibiotic options. Tigecycline has been used mainly as part of a combination regimen for the treatment of some infections and most patients included in these reports had good clinical outcomes. Our study aimed to determine the in-vitro activity of this antibiotic against clinical A. baumannii isolates. Materials and methods: The study was conducted in the university hospital Sheikh Zaid in Rabat. The study included fifty strains of Acinetobacter baumannii isolated from fifty different patients in different units (ICUs, medicine and surgery) Susceptibility testing of these antibiotics was performed according to the method of distributable disks on Mueller Hinton.The interpretation of the minimum inhibitory concentration (MIC) of tigecycline against isolates of A. baumannii was given according to Administration U.S. Food and Drug Administration (FDA). Results: A substantial number of the isolates were found to be resistant to imipenem (80%), ciprofloxacin (88%), amikacin (80%), gentamicin (88%), amoxicillin-clavulanic acid (98%), sulfamethoxazole-trimethoprim (84%) and for all these six antibiotics (70%). Susceptibility to tigecycline varied from 25.71% (susceptible isolates) to 74.29% (intermediate isolates) for 0% (resistant isolates). Conclusion: These in vitro results show that tigecycline has good bacteriostatic activity against A. baumannii, including strains multiresistants.

Keywords: Tigecycline, Multidrug resistant, Acinetobacter baumannii.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More